Biotech ETFs in A Bull Market: Positioning for a Q4 Rally… Part 2..Update
Update-1... 3P September 17 after FED Says No Rate Hike-Biotechs Rally NASDAQ up 0.8% after initial surge Apparently biotech stocks are sensitive to interest rate hikes as many analysts have suggested. Biotech companies need a continual inflow of capital and would be sensitive to higher...
Biotech ETFs Up YTD But 12% Losses in August Creates Downtrend…Update-2.. 9/4
Update -2... 9/8 Rally Time Today Forecasted by Friday's Action ETF Summary -One month and YTD % FBT (12.36), +9.2% IBB (8.9), +11.3% XBI (10.12), +17.27% The five star Fidelity Select Biotech Portfolio (FBIOX) pretty much tracks the IBB up 11.66% YTD and down (8.52) for one month. Three...
Biotech Rally: IBB up 1.8% Just Above 340 LT Support…Update-1
Biotech ETFs Rally Back This Week 8/28 After Close The IBB closed at 353.28 up 0.68% and up 3.95% over 5 days. Next week we will provide an analysis of three ETFs -FBT,IBB and XBI- compared to one large fund the Fidelity Select Biotech Portfolio (FBIOX). All of the ETFs recovered and were...
Biotech Breakdown Leg #2: Another Nasty 4% Hit
Nowhere to Hide in Another 4% Correction 8/25/15 Futures Look Promising at 11p EDT; NIKKEI 225 UP 4.8% Today's market reached epic proportions of volatility and extremes exacerbated by a DOW opening "flash crash" off 1100 points that distorted faith in market mechanics. Several long time market...
Biotech Breakdown: Seeking Relief Today
At Close: IBB down 2.35% to 342 at May bottom, XBI up 0.64% to 218 ---- Two Hours to Go 2:15p EDT, NASDAQ Down 1.79% at 4792, IBB at $349 Biotech Breakdown: Relief Today Or Another Head Fake? Biotech stocks are trying to hold the May lows with the IBB at $342 but now at $349. There is bit of...